Insider Purchases: Inside the Buy

Tag: Science Stocks

Cartoon illustration of Illumina headquarters glowing under a DNA-shaped light beam, with a stock chart climbing in the background and two executives holding shopping bags labeled

🔬 Illumina (ILMN): Let’s Illuminate the Bull Case!

After losing nearly 80% of its value since 2021, Illumina (ILMN) may be ready for a glow-up. CEO Jacob Thaysen and CFO Ankur Dhingra just bought big, and institutional holders are still hanging on. What do they see—and should you see it too?

Read entire article

Tags: Biotech Humor, Biotech Investing, CEO Buys, CEO insider buying, CEOBuyIn, CEOConfidence, CFO Bought Shares, CFO Insider Buying, Contrarian, contrarian investing, Contrarian Play, Contrarian Stocks, ContrarianPlays, DNA Stocks, Funanc1al, Funanc1al for Investors, Funanc1al Investing, Funanc1alInvesting, Future Health Tech, Genomics, Growth Stocks, Illumina, ILMN, ILMN Stock, Innovation Investing, Insider Buys, Science Stocks, Sequencing Stocks, Share buybacks, Turnaround Stocks
Cartoon-style illustration of four lab-coated board directors holding flasks of cash, celebrating in a scientific lab. A beaker labeled

Avantor (AVTR): When 4 Directors Buy Stock After the CEO Quits... You Pay Attention 🧪📦🎯

Four Avantor directors just bought stock after the CEO stepped down. Coincidence? Maybe. Signal of hidden value? Possibly. We analyze the company's numbers, segments, and strategy—one test tube at a time. 🧬📉

Read entire article

Tags: Avantor Stock, AVTR, Biopharma Supply Chain, Biotech Support Industry, CEO Transition Stocks, Funanc1al Investing, Insider Buys, Lab Economy, Science Stocks, value investing, Value Trap or Value Play